Morepen Laboratories Limited
3,686words
18turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
Rs. 2.39
6.5%
Rs.1359.47
39%
Rs.129.39
21.3%
Rs.145.58
44%
Rs.97.71
2.12%
6.45%
Guidance — 20 items
Nine Months Highlights
opening
“in Crores Q2 FY’25 Q3'FY25 442.71 49.06 46.02 34.85 0.65 ) ( ) [ ) [ ) ( ) [ ) ( 458.12 ) ( ) [ ) ( ) [ 41.48 35.21 26.69 0.49 ) ) ) ) ) tiOPEPEH 4.;.”
Operational Perfomance
opening
“in Crores 449 458 2.12% YOY Q3'FY24 Q3'FY25 500 400 300 200 100 0 9M Revenue 9M Revenue Rs.”
Operational Perfomance
opening
“in Crores 1277 1359 6.45% YOY 9M'FY24 9M'FY25 1400 1200 1000 800 600 400 200 0 10% Growth in Exports and 4% increase in Domestic Revenue in 9M’FY25 • Overall demand for the quarter Overall demand for the quarter here was a modest remained muted; tthere was a modest remained muted; 6.45%, growth of 2.12% and% and 6.45%, growth of 2.12 respectively, in Q3 and 9M'FY25.”
Operational Perfomance
opening
“• This quarter's primary focus was on This quarter's primary focus was on high-value markets like Europe, which high-value markets like Europe, which has grown 55% in 9M'FY25.”
Glucometers
opening
“of Strips Sold (crore) (crore) 28.59 32.65 9M'FY24 9M'FY25 13.5mn Customer base with repeat purchase of strips every year 200 150 100 50 0 Cumulative no.”
Blood Pressure Monitors
opening
“of BP Monitors Sold Numbers in lakhs Numbers in lakhs 9.48 8.48 9M'FY24 9M'FY25 10 8 6 4 2 0 Sales Revenue Sales Revenue Rs.”
Operational Perfomance
opening
“10% Increase in Exports of High Value APIs in 9M’FY25 Quarterly Revenue Quarterly Revenue Rs.”
Operational Perfomance
opening
“in Crores 341 335 Q3'FY24 Q3'FY25 350 300 250 200 150 100 50 0 9M Revenue 9M Revenue Rs.”
Operational Perfomance
opening
“in Crores 923 966 5% 9 M'FY24 9 M'FY25 1000 800 600 400 200 0 500 400 300 200 100 0 Rs.”
Operational Perfomance
opening
“in Crores 455 500 10% 9M'FY24 9M'FY25 Pharma Export Growth tiOPEPEH 4.;.”
Risks & concerns — 4 flagged
• Import prices have started rising, Import prices have started rising, while the markets have not responded while the markets have not responded yet, putting pressure on the gross yet, putting pressure on the gross margins.
— Operational Perfomance
Morepen Sync Mobile App ~ orepen s,~ Your Total Logs Last Recorded 12 Dec 2024 24 10 16 Total Blood Glucose logs To!JI Blood Pressure logs Tot.l l We gh!
— Launch of New Mobile App
Morepen - Sync Log and track your key health metrics like blood glucose, blood pressure, weight and much more, effortlessly.
— Launch of New Mobile App
in Crores Gross Revenue Gross Revenue 449 458 2% Q3'FY24 Q3'FY25 500 400 300 200 100 0 24% Lower EBITDA on account of input cost pressure and expenses increase EBITDA %age EBITDA %age 12.18% 9.05% Q3'FY24 Q3'FY25 14 12 10 8 6 4 2 0 Rs.
— Quarterly Performance
Speaking time
4
2
2
1
1
1
1
1
1
1
Opening remarks
Nine Months Highlights
Rs. 2.39 Earnings Per Share (EPS) for the Trailing Twelve Months (TTM) (§)0!§)®1@ 6.5% Gross Revenue Rs.1359.47 cr ~ J3®®~ 39% Profit Before Tax Rs.129.39 cr ~ 22~oJ3®1@ 21.3% EBITDA Rs.145.58 cr ~®I@ 44% Profit After Tax Rs.97.71 cr desc. [ Revenue [ EBITDA [ PBT [ PAT [ EPS (rs.) Rs. in Crores Rs. in Crores Q2 FY’25 Q3'FY25 442.71 49.06 46.02 34.85 0.65 ) ( ) [ ) [ ) ( ) [ ) ( 458.12 ) ( ) [ ) ( ) [ 41.48 35.21 26.69 0.49 ) ) ) ) ) tiOPEPEH 4.;. "'11hl"'1n,;,/ Excclle,1ce ~ ,~ ~ J k INDEX 2 Business Segments Medical Devices 1 Consolidated
Operational Perfomance
Quarterly Revenue Quarterly Revenue Rs. in Crores Rs. in Crores 449 458 2.12% YOY Q3'FY24 Q3'FY25 500 400 300 200 100 0 9M Revenue 9M Revenue Rs. in Crores Rs. in Crores 1277 1359 6.45% YOY 9M'FY24 9M'FY25 1400 1200 1000 800 600 400 200 0 10% Growth in Exports and 4% increase in Domestic Revenue in 9M’FY25 • Overall demand for the quarter Overall demand for the quarter here was a modest remained muted; tthere was a modest remained muted; 6.45%, growth of 2.12% and% and 6.45%, growth of 2.12 respectively, in Q3 and 9M'FY25. respectively, in Q3 and 9M'FY25. • This quarter's primary focus was on This quarter's primary focus was on high-value markets like Europe, which high-value markets like Europe, which has grown 55% in 9M'FY25. has grown 55% in 9M'FY25. • Import prices have started rising, Import prices have started rising, while the markets have not responded while the markets have not responded yet, putting pressure on the gross yet, putting pressure on the gross margins. margins. 40
Glucometers
Cumulative Glucometers Installed Cumulative Glucometers Installed Gluco Strip Sold Gluco Strip Sold 1.16 1.35 No. of Glucometers installed base * No. of Glucometers installed base * (crores) (crores) 14 12 10 8 6 4 2 0 Mar'24 Dec'24 *Cummulative **YTD 35 30 25 20 15 10 5 0 in 9months** No. of Strips Sold in 9months** No. of Strips Sold (crore) (crore) 28.59 32.65 9M'FY24 9M'FY25 13.5mn Customer base with repeat purchase of strips every year 200 150 100 50 0 Cumulative no. Srips Sold* Cumulative no. Srips Sold* (crore) (crore) 187 154 Mar'24 Dec'24 tiOPEPEH 4.;. "'11hl"'1n,;,/ Excclle,1ce ~ ,~ ~ J k Business Segments 2 Medical Devices
Blood Pressure Monitors
No. of BP Monitors Sold No. of BP Monitors Sold Numbers in lakhs Numbers in lakhs 9.48 8.48 9M'FY24 9M'FY25 10 8 6 4 2 0 Sales Revenue Sales Revenue Rs. in Crores Rs. in Crores 63.82 73.45 9M'FY24 9M'FY25 80 60 40 20 0 6.65mn BP Monitors sold till 9M'FY25 with increasing health awareness • Consistent growth in product demand Consistent growth in product demand and expansion into new markets and expansion into new markets • 100% manufacturing in India with 100% manufacturing in India with full backward integration full backward integration • Dedicated SMT lines installed to Dedicated SMT lines installed to ensure regular supply at competitive ensure regular supply at competitive costs costs • Expanding market reach across India Expanding market reach across India and exploring export oppertunities and exploring export oppertunities tiOPEPEH 4.;. • I Ex~li;e;;;ce ~ 2 Medical Devices
Business Update
Capacity Expansion and backward integration in full swing 120K sqft New Facility ready 120K sqft New Facility ready LED Screen Printing Plant started LED Screen Printing Plant started Expansion of BP Monitor Capacity Expansion of BP Monitor Capacity 2 Medical Devices
Business Update
Global Marketing and opportunities on bring evaluated Jan’25 Arab Health, Dubai Jan’25 Arab Health, Dubai Product launch in Qatar, Doha Product launch in Qatar, Doha Medica, Germany Nov’24 Medica, Germany Nov’24 CT CH 2 Medical Devices